ChemicalBook >> CAS DataBase List >>Spesolimab

Spesolimab

CAS No.
2097104-58-8
Chemical Name:
Spesolimab
Synonyms
BI 655130;Spesolimab;Spesolimab (DHJ72801);Spesolimab (anti-IL-1RL2);Research Grade Spesolimab;Research Grade Spesolimab(DHJ72801)
CBNumber:
CB28081111
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-04-24 14:58:55

Spesolimab Properties

form Liquid
color Colorless to light yellow
FDA UNII 5IB2J79MCX

Spesolimab price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0624043 Spesolimab 99.10% 2097104-58-8 1mg $466 2026-06-04 Buy
ChemScene CS-0624043 Spesolimab 99.10% 2097104-58-8 5mg $1213 2026-06-04 Buy
ChemScene CS-0624043 Spesolimab 99.10% 2097104-58-8 10mg $1950 2026-06-04 Buy
aablocks AA029J72 Spesolimab 2097104-58-8 1mg $247 2026-06-02 Buy
aablocks AA029J72 Spesolimab 2097104-58-8 5mg $614 2026-06-02 Buy
Product number Packaging Price Buy
CS-0624043 1mg $466 Buy
CS-0624043 5mg $1213 Buy
CS-0624043 10mg $1950 Buy
AA029J72 1mg $247 Buy
AA029J72 5mg $614 Buy

Spesolimab Chemical Properties, Uses, Production

Uses

Spesolimab (BI 655130) is a mouse-derived humanized IgG1k antibody against IL-36R. IL-36 plays an important role in the immune system and Spesolimab is being investigated in palmoplantar pustulosis (PPP). Spesolimab was associated with a reduction in biomarkers associated with the innate, Th1/Th17 and neutrophil pathways[1][2][3][4].

References

[1] Mrowietz U, et al. Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study. Dermatol Ther (Heidelb). 2021 Apr;11(2):571-585. DOI:10.1007/s13555-021-00504-0
[2] Geller S, et al. CCR4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders and its implications for diagnosis and treatment[C]//Journal of Investigative Dermatology. STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA: ELSEVIER SCIENCE INC, 2019, 139(9): B25-B25.
[3] Jennifer Ahlberg, et al. Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5). MAbs. 2019 Jul;11(5):956-964. DOI:10.1080/19420862.2019.1615345
[4] Rajkumar Ganesan, et al. Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies.MAbs. 2017 Oct;9(7):1143-1154. DOI:10.1080/19420862.2017.1353853

Spesolimab Preparation Products And Raw materials

Raw materials

Preparation Products

Spesolimab Suppliers

Global Suppliers ( 24)
Supplier Tel Email Country ProdList Advantage
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
ShangHai Biochempartner Co.,Ltd 177-54423994 17754423994 2853530910@QQ.com China 8000 62
Guangzhou Hongyuan Chemical Co.,Ltd 15817493340 981810490@qq.com China 1577 58
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10305 58
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 psaitong@jm-bio.com China 27626 58
TargetMol Chemicals Inc. 4008200310 15002144251 marketing@tsbiochem.com China 24951 58
Biolab Reagents 027-65279366 18108604356 products@biolabreagent.com China 9864 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 086-15871494362 13720134139 orders@jknbiochem.com China 7283 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
Wuhan Acumen Bio-Technology Co.,ltd 027-027-16602739303 16602739303 673003916@qq.com China 4593 58
Spesolimab Spesolimab (DHJ72801) Research Grade Spesolimab(DHJ72801) Research Grade Spesolimab BI 655130 Spesolimab (anti-IL-1RL2) 2097104-58-8